Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors - Eigentler, Thomas; Krauss, Juergen; Schreiber, Jutta; Weishaupt, Carsten; Terheyden, Patrick; Heinzerling, Lucie; Mohr, Peter; Weide, Benjamin; Gutzmer, Ralf; Becker, Juergen C.; Kiecker, Felix; Daehling, Angelika; et al. (CANCER RESEARCH, 2019)
CRIS-Team WoS Importer:2019-10-15